vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and ThredUp Inc. (TDUP). Click either name above to swap in a different company.
ThredUp Inc. is the larger business by last-quarter revenue ($79.7M vs $44.9M, roughly 1.8× AbCellera Biologics Inc.). ThredUp Inc. runs the higher net margin — -7.0% vs -19.9%, a 12.9% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 18.5%). ThredUp Inc. produced more free cash flow last quarter ($-3.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 11.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
ThredUp Inc. is an American company that operates an online resale platform specializing in the sale of second-hand clothing, footwear, and accessories. Founded in 2009 and headquartered in Oakland, California, it has established itself as one of the leading resale fashion marketplaces.
ABCL vs TDUP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $79.7M |
| Net Profit | $-8.9M | $-5.6M |
| Gross Margin | — | 79.6% |
| Operating Margin | -63.7% | -8.4% |
| Net Margin | -19.9% | -7.0% |
| Revenue YoY | 788.4% | 18.5% |
| Net Profit YoY | 73.9% | 74.3% |
| EPS (diluted) | $-0.03 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $79.7M | ||
| Q3 25 | $9.0M | $82.2M | ||
| Q2 25 | $17.1M | $77.7M | ||
| Q1 25 | $4.2M | $71.3M | ||
| Q4 24 | $5.0M | $67.3M | ||
| Q3 24 | $6.5M | $61.5M | ||
| Q2 24 | $7.3M | $66.7M | ||
| Q1 24 | $10.0M | $64.5M |
| Q4 25 | $-8.9M | $-5.6M | ||
| Q3 25 | $-57.1M | $-4.2M | ||
| Q2 25 | $-34.7M | $-5.2M | ||
| Q1 25 | $-45.6M | $-5.2M | ||
| Q4 24 | — | $-21.7M | ||
| Q3 24 | $-51.1M | $-24.8M | ||
| Q2 24 | $-36.9M | $-14.0M | ||
| Q1 24 | $-40.6M | $-16.6M |
| Q4 25 | — | 79.6% | ||
| Q3 25 | — | 79.4% | ||
| Q2 25 | — | 79.5% | ||
| Q1 25 | — | 79.1% | ||
| Q4 24 | — | 80.4% | ||
| Q3 24 | — | 79.3% | ||
| Q2 24 | — | 78.8% | ||
| Q1 24 | — | 80.1% |
| Q4 25 | -63.7% | -8.4% | ||
| Q3 25 | -851.8% | -5.3% | ||
| Q2 25 | -290.2% | -6.8% | ||
| Q1 25 | -1479.6% | -7.6% | ||
| Q4 24 | — | -12.1% | ||
| Q3 24 | -1439.4% | -17.0% | ||
| Q2 24 | -1276.2% | -14.4% | ||
| Q1 24 | -551.5% | -19.2% |
| Q4 25 | -19.9% | -7.0% | ||
| Q3 25 | -637.8% | -5.2% | ||
| Q2 25 | -203.3% | -6.7% | ||
| Q1 25 | -1077.2% | -7.3% | ||
| Q4 24 | — | -32.3% | ||
| Q3 24 | -785.4% | -40.3% | ||
| Q2 24 | -504.3% | -20.9% | ||
| Q1 24 | -408.0% | -25.7% |
| Q4 25 | $-0.03 | $-0.06 | ||
| Q3 25 | $-0.19 | $-0.03 | ||
| Q2 25 | $-0.12 | $-0.04 | ||
| Q1 25 | $-0.15 | $-0.04 | ||
| Q4 24 | — | $-0.19 | ||
| Q3 24 | $-0.17 | $-0.22 | ||
| Q2 24 | $-0.13 | $-0.13 | ||
| Q1 24 | $-0.14 | $-0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $38.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $59.2M |
| Total Assets | $1.4B | $167.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $38.6M | ||
| Q3 25 | $83.2M | $46.2M | ||
| Q2 25 | $92.4M | $41.0M | ||
| Q1 25 | $159.3M | $41.1M | ||
| Q4 24 | $156.3M | $31.9M | ||
| Q3 24 | $126.6M | $43.7M | ||
| Q2 24 | $148.3M | $44.8M | ||
| Q1 24 | $123.6M | $50.1M |
| Q4 25 | $966.9M | $59.2M | ||
| Q3 25 | $964.0M | $59.1M | ||
| Q2 25 | $1.0B | $60.2M | ||
| Q1 25 | $1.0B | $56.1M | ||
| Q4 24 | $1.1B | $56.3M | ||
| Q3 24 | $1.1B | $69.3M | ||
| Q2 24 | $1.1B | $86.5M | ||
| Q1 24 | $1.1B | $93.5M |
| Q4 25 | $1.4B | $167.2M | ||
| Q3 25 | $1.4B | $172.5M | ||
| Q2 25 | $1.4B | $173.6M | ||
| Q1 25 | $1.3B | $172.5M | ||
| Q4 24 | $1.4B | $171.2M | ||
| Q3 24 | $1.4B | $214.9M | ||
| Q2 24 | $1.4B | $231.2M | ||
| Q1 24 | $1.5B | $244.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-1.5M |
| Free Cash FlowOCF − Capex | $-44.6M | $-3.2M |
| FCF MarginFCF / Revenue | -99.4% | -4.0% |
| Capex IntensityCapex / Revenue | 21.9% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-1.5M | ||
| Q3 25 | $-52.6M | $6.0M | ||
| Q2 25 | $-32.4M | $344.0K | ||
| Q1 25 | $-11.6M | $5.7M | ||
| Q4 24 | $-108.6M | $663.0K | ||
| Q3 24 | $-28.9M | $3.3M | ||
| Q2 24 | $-30.0M | $-5.0M | ||
| Q1 24 | $-41.7M | $1.4M |
| Q4 25 | $-44.6M | $-3.2M | ||
| Q3 25 | $-61.5M | $2.4M | ||
| Q2 25 | $-45.8M | $-2.9M | ||
| Q1 25 | $-22.2M | $3.9M | ||
| Q4 24 | $-187.0M | $-1.8M | ||
| Q3 24 | $-47.4M | $1.2M | ||
| Q2 24 | $-50.1M | $-5.8M | ||
| Q1 24 | $-65.8M | $267.0K |
| Q4 25 | -99.4% | -4.0% | ||
| Q3 25 | -687.0% | 2.9% | ||
| Q2 25 | -267.9% | -3.8% | ||
| Q1 25 | -524.0% | 5.5% | ||
| Q4 24 | -3702.8% | -2.7% | ||
| Q3 24 | -728.4% | 2.0% | ||
| Q2 24 | -683.8% | -8.7% | ||
| Q1 24 | -661.5% | 0.4% |
| Q4 25 | 21.9% | 2.2% | ||
| Q3 25 | 99.7% | 4.4% | ||
| Q2 25 | 78.2% | 4.2% | ||
| Q1 25 | 251.1% | 2.5% | ||
| Q4 24 | 1552.7% | 3.7% | ||
| Q3 24 | 284.6% | 3.5% | ||
| Q2 24 | 274.6% | 1.3% | ||
| Q1 24 | 242.5% | 1.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
